H2A.Z护航者聚集在黑色素瘤细胞增殖的E2F点基因上
Sina Jostes1,2,3, Chiara Vardabasso1,2, Joanna Dong1,2
1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York 10029, USA.
Genes & development
|May 14, 2024
概括
高的H2A.Z水平驱动黑色素瘤的生长. 针对其伴侣SRCAP,P400和YL1,影响细胞周期基因和H4乙化,为黑色素瘤治疗提供新的表观遗传策略.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 高水平的H2A.Z与黑色素瘤的扩散和不良预后有关.
- 在黑色素瘤中,H2A.Z 基因伴复合体 (SRCAP 和 P400-TIP60) 的特定作用尚不清楚.
研究的目的:
- 为了研究黑色素瘤中H2A.Z伴侣复合体 (SRCAP,P400和VPS72/YL1) 的单个子单元的功能.
- 探索黑色素瘤细胞周期控制中的H2A.Z沉积和H4乙化的协调调节.
主要方法:
- 在黑色素瘤细胞中的单个子单元 (SRCAP,P400,VPS72) 的耗尽.
- 对H2A.Z沉积和H4乙化水平的分析.
- 评估细胞周期基因表达,E2F1活性和亡诱导.
- 在黑色素瘤组织中,YL1表达与患者结局的相关性分析.
主要成果:
- 在细胞循环基因促进剂中,SRCAP,P400或VPS72的耗尽减少了H2A.Z沉积和H4乙化.
- 这些子单元的破坏导致了E2F1的下调,细胞循环停止,在YL1的情况下,导致了细胞亡.
- 在黑色素瘤中YL1过度表达,并与较差的患者结局有关.
结论:
- SRCAP,P400和YL1协调H2A.Z沉积和H4乙化以促进黑色素瘤细胞的增殖.
- YL1在诱导亡中的作用及其过度表达突出了其作为治疗点的潜力.
- 准H2A.Z陪伴者是一个有前途的表观遗传策略,用于治疗黑色素瘤.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
DNA Damage can Stall the Cell Cycle
9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Molecular Factors Affecting Cell Division
3.1K
Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.1K


